216 related articles for article (PubMed ID: 38349176)
21. Plasma-based strategy for inhibiting Candida albicans growth and CaMCA1 gene expression in vitro and reducing fungal pathogenicity in a murine model of vulvovaginal candidiasis.
Ebrahimi-Shaghaghi F; Atyabi SM; Razzaghi-Abyaneh M
Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34694384
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.
Vicariotto F; Del Piano M; Mogna L; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S73-80. PubMed ID: 22955364
[TBL] [Abstract][Full Text] [Related]
23. Candidalysin Crucially Contributes to Nlrp3 Inflammasome Activation by Candida albicans Hyphae.
Rogiers O; Frising UC; Kucharíková S; Jabra-Rizk MA; van Loo G; Van Dijck P; Wullaert A
mBio; 2019 Jan; 10(1):. PubMed ID: 30622184
[No Abstract] [Full Text] [Related]
24. [Pulsatilla decoction inhibits vulvovaginal Candida albicans proliferation and reduces inflammatory cytokine levels in vulvovaginal candidiasis mice].
Xia D; Zhang M; Shi G; Xu Z; Wu D; Shao J; Wang T; Wang C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):153-7. PubMed ID: 26927371
[TBL] [Abstract][Full Text] [Related]
25. Candidalysins Are a New Family of Cytolytic Fungal Peptide Toxins.
Richardson JP; Brown R; Kichik N; Lee S; Priest E; Mogavero S; Maufrais C; Wickramasinghe DN; Tsavou A; Kotowicz NK; Hepworth OW; Gallego-Cortés A; Ponde NO; Ho J; Moyes DL; Wilson D; D'Enfert C; Hube B; Naglik JR
mBio; 2022 Feb; 13(1):e0351021. PubMed ID: 35073742
[TBL] [Abstract][Full Text] [Related]
26. Candidalysin, a Virulence Factor of Candida albicans, Stimulates Mast Cells by Mediating Cross-Talk Between Signaling Pathways Activated by the Dectin-1 Receptor and MAPKs.
Song P; Peng G; Yue H; Ogawa T; Ikeda S; Okumura K; Ogawa H; Niyonsaba F
J Clin Immunol; 2022 Jul; 42(5):1009-1025. PubMed ID: 35420364
[TBL] [Abstract][Full Text] [Related]
27. Vaginal homeostasis features of Vulvovaginal Candidiasis through vaginal metabolic profiling.
Chen X; Wang J; Chen J; Wang G; Zhang R; Qiu J
Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37573133
[TBL] [Abstract][Full Text] [Related]
28. Biased genotype distributions of Candida albicans strains associated with vulvovaginal candidosis and candidal balanoposthitis in China.
Li J; Fan SR; Liu XP; Li DM; Nie ZH; Li F; Lin H; Huang WM; Zong LL; Jin JG; Lei H; Bai FY
Clin Infect Dis; 2008 Nov; 47(9):1119-25. PubMed ID: 18808351
[TBL] [Abstract][Full Text] [Related]
29. Candidalysin activates innate epithelial immune responses via epidermal growth factor receptor.
Ho J; Yang X; Nikou SA; Kichik N; Donkin A; Ponde NO; Richardson JP; Gratacap RL; Archambault LS; Zwirner CP; Murciano C; Henley-Smith R; Thavaraj S; Tynan CJ; Gaffen SL; Hube B; Wheeler RT; Moyes DL; Naglik JR
Nat Commun; 2019 May; 10(1):2297. PubMed ID: 31127085
[TBL] [Abstract][Full Text] [Related]
30. The bacterial communities in vagina of different Candida species-associated vulvovaginal candidiasis.
Chen Z; Jin J; Chen H; Chen Y; Feng S
Microb Pathog; 2023 Apr; 177():106037. PubMed ID: 36842517
[TBL] [Abstract][Full Text] [Related]
31. The
Russell CM; Schaefer KG; Dixson A; Gray ALH; Pyron RJ; Alves DS; Moore N; Conley EA; Schuck RJ; White TA; Do TD; King GM; Barrera FN
Elife; 2022 Sep; 11():. PubMed ID: 36173096
[TBL] [Abstract][Full Text] [Related]
32. Longdan Xiegan decoction ameliorates vulvovaginal candidiasis by inhibiting the NLRP3 inflammasome via the Toll-like receptor /MyD88 pathway.
Feng X; Zhang H; Hu K; Shi G; Wu D; Shao J; Wang T; Wang C
J Ethnopharmacol; 2024 Jan; 318(Pt A):116869. PubMed ID: 37390876
[TBL] [Abstract][Full Text] [Related]
33. Zinc prevents vaginal candidiasis by inhibiting expression of an inflammatory fungal protein.
Roselletti E; Pericolini E; Nore A; Takacs P; Kozma B; Sala A; De Seta F; Comar M; Usher J; Brown GD; Wilson D
Sci Transl Med; 2023 Dec; 15(725):eadi3363. PubMed ID: 38055800
[No Abstract] [Full Text] [Related]
34. Divergent EGFR/MAPK-Mediated Immune Responses to Clinical
Zhang J; Peng J; Li D; Mei H; Yu Y; Li X; She X; Liu W
Front Immunol; 2022; 13():894069. PubMed ID: 35720274
[TBL] [Abstract][Full Text] [Related]
35. Analysis of pathogenic factors of Candida albicans and the effect of vaginal immunization on recurrent vulvovaginal candidiasis in mice.
Shao MK; Qi WJ; Hou MY; Luo DD
J Obstet Gynaecol Res; 2022 Mar; 48(3):857-865. PubMed ID: 34970814
[TBL] [Abstract][Full Text] [Related]
36. IL-9 Integrates the Host-
Renga G; Borghi M; Oikonomou V; Mosci P; Bartoli A; Renauld JC; Romani L; Costantini C
Front Immunol; 2018; 9():2702. PubMed ID: 30515173
[TBL] [Abstract][Full Text] [Related]
37. Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis.
Ge G; Yang Z; Li D; Zhang N; Chen B; Shi D
Front Immunol; 2022; 13():959740. PubMed ID: 35967437
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
[TBL] [Abstract][Full Text] [Related]
39. [Effect of butyl alcohol extract of Baitouweng Decoction on epithelial barrier of vaginal mucosa in mice with vulvovaginal candidiasis].
Ting Z; Ya-Dong W; Kang Z; Meng-Xiang Z; Qiang-Jun D; Tian-Ming W; Jing S; Chang-Zhong W
Zhongguo Zhong Yao Za Zhi; 2020 Oct; 45(20):4991-4996. PubMed ID: 33350274
[TBL] [Abstract][Full Text] [Related]
40. Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy.
Sun Z; Ge X; Qiu B; Xiang Z; Jiang C; Wu J; Li Y
Front Cell Infect Microbiol; 2023; 13():1123026. PubMed ID: 36816582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
